Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. (1r,2s)-1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(3-fluorophenyl)-1-phenyl-butan-2-ol
2. Aids-222089
3. Aids222088
4. Bedaquiline
5. R207910
6. Tmc207
1. 845533-86-0
2. Bedaquiline (fumarate)
3. Sirturo
4. R403323
5. Bedaquiline Fumarate [usan]
6. P04qx2c1a5
7. Chebi:72295
8. 845533-86-0 (fumarate)
9. R-403323
10. R 403323
11. Unii-p04qx2c1a5
12. (1r,2s)-1-(6-bromo-2-methoxy-3-quinolyl)-4-dimethylamino-2-(1-naphthyl)-1-phenyl-butan-2-ol Fumarate
13. Bedaquilinefumarate
14. Sirturo (tn)
15. Chembl2105700
16. Schembl20496928
17. Bedaquiline Fumarate [mi]
18. Bedaquiline Fumarate; R403323
19. Bedaquiline Fumarate (jan/usan)
20. Bedaquiline Fumarate [jan]
21. Dtxsid401004837
22. Ex-a2647
23. Hy-14881a
24. S4854
25. Bedaquiline Fumarate [who-dd]
26. Ccg-270358
27. Ac-28750
28. As-57710
29. Bedaquiline Fumarate [orange Book]
30. D09873
31. R403323;tmc207 Fumarate;r207910 Fumarate
32. Q27139886
33. (1r,2s)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenylbutan-2-ol Bis[(2z)-but-2-enedioate]
34. (1r,2s)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1- Phenylbutan-2-ol (2e)-but-2-enedioate Salt (1:1)
35. (1r,2s)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol Fumarate
36. (1r,2s)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol;(e)-but-2-enedioic Acid
37. 3-quinolineethanol, 6-bromo-.alpha.-(2-(dimethylamino)ethyl)-2-methoxy-.alpha.-1-naphthalenyl-.beta.-phenyl-, (.alpha.s,.beta.r)-, (2e)-2-butenedioate (1:1) (salt)
38. 3-quinolineethanol, 6-bromo-alpha-(2-(dimethylamino)ethyl)-2-methoxy-alpha-1-naphthalenyl- -phenyl-, (s,r)-, (2e)-2-butenedioate (1:1) (salt)
39. 6-bromo-3-[(1r,2s)-4-(dimethylammonio)-2-hydroxy-2-(1-naphthyl)-1-phenylbutyl]-2-methoxyquinolinium (2e)-but-2-enedioate
| Molecular Weight | 671.6 g/mol |
|---|---|
| Molecular Formula | C36H35BrN2O6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 670.16785 g/mol |
| Monoisotopic Mass | 670.16785 g/mol |
| Topological Polar Surface Area | 120 Ų |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 834 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Sirturo is indicated for use as part of an appropriate combination regimen for pulmonary multidrug resistant tuberculosis (MDR TB) in adults and adolescent patients (12 years to less than 18 years of age and weighing at least 30 kg) when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Antitubercular Agents
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. (See all compounds classified as Antitubercular Agents.)
J04AK05
Related Excipient Companies
Excipients by Applications
Global Sales Information
Company : Janssen Product
Bedaquiline Fumarate
Drug Cost (USD) : 3,019,486
Year : 2023
Prescribers : 105
Prescriptions : 645

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Janssen Product
Bedaquiline Fumarate
Drug Cost (USD) : 2,147,056
Year : 2022
Prescribers : 83
Prescriptions : 478

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Janssen Product
Bedaquiline Fumarate
Drug Cost (USD) : 2,041,547
Year : 2021
Prescribers : 81
Prescriptions : 441

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Janssen Product
Bedaquiline Fumarate
Drug Cost (USD) : 1,579,345
Year : 2020
Prescribers : 58
Prescriptions : 345

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Janssen Product
Bedaquiline Fumarate
Drug Cost (USD) : 979,814
Year : 2019
Prescribers : 39
Prescriptions : 217

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Janssen Product
Bedaquiline Fumarate
Drug Cost (USD) : 589,215
Year : 2018
Prescribers : 23
Prescriptions : 123

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Bedaquilina 100Mg 188 Unita' Ora...
Dosage Strength : 188 CPR 100 mg bottle
Price Per Pack (Euro) : 33,109.50
Published in :
Country : Italy
RX/OTC/DISCN : Class H

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
01 Dec 2025
Reply
16 Jun 2025
Reply
29 Aug 2024
Reply
09 May 2023
Reply
15 Dec 2020
Reply
26 Oct 2020
Reply
08 Jul 2019
Reply
15 Sep 2018

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Patents & EXCLUSIVITIES
Patent Expiration Date : 2029-03-19
US Patent Number : 8546428
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204384
Patent Use Code : U-1321
Delist Requested :
Patent Use Description : TREATMENT OF PULMONARY...
Patent Expiration Date : 2029-03-19

Patent Expiration Date : 2029-03-19
US Patent Number : 8546428
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204384
Patent Use Code : U-1321
Delist Requested :
Patent Use Description : TREATMENT OF PULMONARY...
Patent Expiration Date : 2029-03-19

Patent Expiration Date : 2026-12-01
US Patent Number : 7498343
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204384
Patent Use Code : U-1321
Delist Requested :
Patent Use Description : TREATMENT OF PULMONARY...
Patent Expiration Date : 2026-12-01

Patent Expiration Date : 2026-12-01
US Patent Number : 7498343
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204384
Patent Use Code : U-1321
Delist Requested :
Patent Use Description : TREATMENT OF PULMONARY...
Patent Expiration Date : 2026-12-01

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Bedaquiline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bedaquiline manufacturer or Bedaquiline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bedaquiline manufacturer or Bedaquiline supplier.
A Bedaquiline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bedaquiline, including repackagers and relabelers. The FDA regulates Bedaquiline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bedaquiline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bedaquiline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Bedaquiline supplier is an individual or a company that provides Bedaquiline active pharmaceutical ingredient (API) or Bedaquiline finished formulations upon request. The Bedaquiline suppliers may include Bedaquiline API manufacturers, exporters, distributors and traders.
click here to find a list of Bedaquiline suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Bedaquiline DMF (Drug Master File) is a document detailing the whole manufacturing process of Bedaquiline active pharmaceutical ingredient (API) in detail. Different forms of Bedaquiline DMFs exist exist since differing nations have different regulations, such as Bedaquiline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bedaquiline DMF submitted to regulatory agencies in the US is known as a USDMF. Bedaquiline USDMF includes data on Bedaquiline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bedaquiline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bedaquiline suppliers with USDMF on PharmaCompass.
A Bedaquiline written confirmation (Bedaquiline WC) is an official document issued by a regulatory agency to a Bedaquiline manufacturer, verifying that the manufacturing facility of a Bedaquiline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Bedaquiline APIs or Bedaquiline finished pharmaceutical products to another nation, regulatory agencies frequently require a Bedaquiline WC (written confirmation) as part of the regulatory process.
click here to find a list of Bedaquiline suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bedaquiline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bedaquiline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bedaquiline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bedaquiline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bedaquiline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bedaquiline suppliers with NDC on PharmaCompass.
Bedaquiline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bedaquiline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bedaquiline GMP manufacturer or Bedaquiline GMP API supplier for your needs.
A Bedaquiline CoA (Certificate of Analysis) is a formal document that attests to Bedaquiline's compliance with Bedaquiline specifications and serves as a tool for batch-level quality control.
Bedaquiline CoA mostly includes findings from lab analyses of a specific batch. For each Bedaquiline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bedaquiline may be tested according to a variety of international standards, such as European Pharmacopoeia (Bedaquiline EP), Bedaquiline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bedaquiline USP).